{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:42:49Z","timestamp":1791538969015,"version":"4.3.4"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hypokalemia is a common clinical condition that can lead to muscle weakness, difficulty breathing, malignant arrhythmias, and even death. This report describes two cases of severe hypokalemia resulting from the use of electronic cigarettes containing etomidate, both accompanied by varying degrees of adrenal hyperplasia. In both cases, the patients were admitted to the hospital with lower limb weakness and difficulty walking. Relevant examinations revealed low blood potassium, low cortisol, high adrenocorticotropic hormone, low renin, and low aldosterone levels in the patients, with Case 2 also having significant hypertension. In both cases, adrenal CT scans showed thickening of the adrenal glands. After the delivery of potassium supplementation in both cases, blood potassium levels gradually returned to normal and muscle strength gradually improved. The case reports are followed by a review of the literature on etomidate and its related mechanisms of action with discussion of its association with hypokalemia.<\/jats:p>","DOI":"10.3389\/fendo.2024.1321610","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:38:31Z","timestamp":1717029511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Etomidate-induced hypokalemia in electronic cigarette users: two case reports and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Wenchang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01038-6","article-title":"Etomidate and its analogs: A review of pharmacokinetics and pharmacodynamics","volume":"60","author":"Valk","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199205000-00010","article-title":"Sympathetic responses to induction of anesthesia in humans with propofol or etomidate","volume":"76","author":"Ebert","year":"1992","journal-title":"Anesthesiology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200310000-00022","article-title":"Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate","volume":"99","author":"Paris","year":"2003","journal-title":"Anesthesiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1213\/00000539-198907000-00007","article-title":"Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol","volume":"69","author":"Brussel","year":"1989","journal-title":"Anesth Analg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.14740\/jem682","article-title":"A case of etomidate use in management of adrenocortical carcinoma with hypercortisolemia","volume":"10","author":"Wan Muhamad Hatta","year":"2020","journal-title":"J Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12296","DOI":"10.1038\/s41598-022-16679-1","article-title":"Effects of etomidate combined with dexmedetomidine on adrenocortical function in elderly patients: a double-blind randomized controlled trial","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12871-023-02090-4","article-title":"Effect of vitamin C on adrenal suppression following etomidate for rapid sequence induction in trauma patients: a randomized clinical trial","volume":"23","author":"Panahi","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-2044.2005.04519_1.x","article-title":"Etomidate and ECT","volume":"61","author":"Ryding","year":"2006","journal-title":"Anaesthesia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.34172\/ijdrc.2023.e1","article-title":"The magical role of vitamin C on adrenal insufficiency subsequent to etomidate administration: ongoing challenges in the management of trauma patients","volume":"1","author":"Soleimanpour","year":"2023","journal-title":"Int J Drug Res Clinics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1869539433","DOI":"10.1177\/20420188211058583","article-title":"Pharmacological management of severe Cushing\u2019s syndrome: the role of etomidate","volume":"13","author":"Pence","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2131\/jts.44.575","article-title":"Physiological and drug-induced changes in blood levels of adrenal steroids and their precursors in cynomolgus monkeys: An application of steroid profiling by LC-MS\/MS for evaluation of the adrenal toxicity","volume":"44","author":"Tochitani","year":"2019","journal-title":"J Toxicol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00134-022-06671-8","article-title":"Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial","volume":"48","author":"Matchett","year":"2022","journal-title":"Intensive Care Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.846865","article-title":"11-deoxycorticosterone producing adrenal hyperplasia as a very unusual cause of endocrine hypertension: case report and systematic review of the literature","volume":"13","author":"Asla","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.893410","article-title":"Comparison of adrenal suppression between etomidate and dexmedetomidine in children with congenital heart disease","volume":"21","author":"Gu","year":"2015","journal-title":"Med Sci Monit"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27903","article-title":"Dexmedetomidine versus propofol at different sedation depths during drug-induced sleep endoscopy: A randomized trial","volume":"130","author":"Padiyara","year":"2020","journal-title":"Laryngoscope"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-022-00397-4","article-title":"Cushing\u2019s syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia","volume":"21","author":"Dzialach","year":"2022","journal-title":"Hormones (Athens)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1321610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:38:35Z","timestamp":1717029515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1321610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":17,"alternative-id":["10.3389\/fendo.2024.1321610"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1321610","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"article-number":"1321610"}}